agilon health, inc. (AGL) Stock Analysis: Evaluating a 35% Potential Upside
Analyst sentiment towards agilon health shows a mixed yet optimistic outlook. With 5 “Buy” ratings, 9 “Hold” ratings, and ...
Model output · Signal date 2026-10-14
Agilon Health, Inc. (AGL) Stock Forecast Oct. 14, 2026
Analysis updated on Oct. 14, 2026 (UTC) · Total · absolute moveSwitch to Alpha · NYSE
Rating · 90D
▲ Bullish
Exact rating locked
90-day forecast
Sign up free to reveal
30-day forecast
Total
Rank in coverage
Top 35%
of 4009 stocks scored
Rank correlation · 90D
n/a
No per-ticker sample yet
Market Cap
$1.44B
small-cap · #5 of 11 peers
Summary
Agilon Health, Inc. (AGL) stock forecast summary
Our AI ranks Agilon Health, Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Agilon Health, Inc. is a small-cap company with a market capitalization of $1.44B. It ranks number 5 by market capitalization among the 11 Services-Misc Health & Allied Services, NEC issuers in our coverage with a current forecast. Its D/E Ratio of 5.99x is the highest of the 9 peers that report one.
A per-ticker accuracy statistic for AGL is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected absolute price move over the horizon, market included. This is the number a price target is built from. Ratings: strong buy ≥ +4.5%, buy ≥ +3.4%, sell < +2.1%, strong sell < +0.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-14 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, AGL included.
Follow AGL freePrice
AGL price chart and AI forecast
Cross-section · 2026-10-14
How AGL ranks among 4009 stocks
90D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Fundamentals
Agilon Health, Inc. (AGL) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Services-Misc Health & Allied Services, NEC peers listed below that report each metric.
Valuation & Market
| Metric | AGL | Rank |
|---|---|---|
| Market Cap | $1.44B | 5/11 |
| P/B Ratio | 6.34x | 2/7 |
| EPS | $-14.27 | – |
| Book Value/Share | $13.55 | – |
| Revenue/Share | $352.57 | – |
| FCF/Share | $-5.06 | – |
Profitability & Margins
| Metric | AGL | Rank |
|---|---|---|
| ROE | -102.1% | 5/7 |
| ROA | -14.6% | 7/10 |
| ROIC | -110.9% | 7/8 |
| Operating Margin | -5.2% | 6/9 |
| Net Margin | -3.9% | 6/10 |
| EBT Margin | -4.3% | 6/10 |
| Tax Rate | -0.3% | – |
Financial Health
| Metric | AGL | Rank |
|---|---|---|
| Current Ratio | 1.08x | 8/11 |
| D/E Ratio | 5.99x | 1/9 |
| Financial Leverage | 6.99x | 1/9 |
| Interest Coverage | 5.7x | 5/12 |
| Working Capital | $106M | 4/11 |
Cash Flow
| Metric | AGL | Rank |
|---|---|---|
| Operating Cash Flow | -$72M | 11/11 |
| Free Cash Flow | -$85M | 7/7 |
| Capital Spending | -$13M | 3/7 |
| FCF/Sales | -1.4% | 7/7 |
| CapEx/Sales | 0.2% | 7/7 |
Operational Efficiency
| Metric | AGL | Rank |
|---|---|---|
| Asset Turnover | 3.72x | 1/9 |
| Receivables Turnover | 5.6x | 6/9 |
| Fixed Assets Turnover | 241.5x | 1/8 |
| Days Sales Outstanding | 65 days | 4/9 |
Income Statement
| Metric | AGL | Rank |
|---|---|---|
| Total Revenue | $5.92B | 2/9 |
| Operating Income | -$309M | 10/10 |
| Net Income | -$232M | 10/10 |
Dividend & Shareholder Information
| Metric | AGL | Rank |
|---|---|---|
| Shares Outstanding | 17M | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $1.42B | 89.1% of assets |
| Cash & Short-term Investments | $107M | 6.7% of assets |
| Accounts Receivable | $1.06B | 66.6% of assets |
| Total Liabilities | $1.36B | 85.7% of assets |
Quarterly Financial Reports
AGL quarterly financials and insider trading
Industry Peers · Services-Misc Health & Allied Services, NEC
Agilon Health, Inc. (AGL) industry peers
Companies classified under the same SEC industry code as Agilon Health, Inc. (Services-Misc Health & Allied Services, NEC): 13 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Total) | Market Cap |
|---|---|---|
| AGL Agilon Health, Inc. | ▲ | $1.44B |
| DVA Davita Inc. | ▶ | $11.62B |
| FMS Fresenius Medical Care Ag | ▼ | $5.89B |
| SHC Sotera Health Co | ▶ | $5.20B |
| PGNY Progyny, Inc. | ▶ | $2.10B |
| VMD Viemed Healthcare, Inc. | ▶ | $366M |
| PARK Park Dental Partners, Inc. | ▶ | $93M |
| MRAI Marpai, Inc. | ▲ | $86M |
| CCEL Cryo Cell International Inc | ▶ | $35M |
| PFHO Pacific Health Care Organization Inc | ▶ | $12M |
| MGRX Mangoceuticals, Inc. | ▶ | $8M |
| BRTX Biorestorative Therapies, Inc. | ▼ | N/A |
| NIVF Newgenivf Group Ltd | ▼ | N/A |
Where AGL sits on the market map
Industrial Applications and Services · Services-Misc Health & Allied Services, NEC
News
Agilon Health, Inc. (AGL) stock news
Deadline Approaching: agilon health, inc. (AGL) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming March 2, 2026 deadline to file a lead plaintiff motion in the case filed on behalf of investors who ...
agilon health, inc. (AGL) Q1 2026 Earnings Call Transcript
Thank you, operator. Good afternoon, and welcome to the call. With me are Executive Chairman, Ron Williams; and our CFO, Jeff Schwaneke. Following our prepared remarks, we will conduct a Q&A session.
FAQ
Agilon Health, Inc. (AGL) stock forecast FAQ
What is the Agilon Health, Inc. (AGL) stock forecast?
Our AI ranks Agilon Health, Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
How accurate are Agilon Health, Inc. stock predictions?
A per-ticker accuracy statistic for AGL is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Agilon Health, Inc. forecasts updated?
Agilon Health, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 14, 2026.
Which companies are Agilon Health, Inc.'s industry peers?
13 issuers in our coverage, AGL included, share the SEC industry code Services-Misc Health & Allied Services, NEC. The largest are: Davita Inc. (DVA), Fresenius Medical Care Ag (FMS), Sotera Health Co (SHC), Progyny, Inc. (PGNY), Viemed Healthcare, Inc. (VMD), Park Dental Partners, Inc. (PARK).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.